S. Bruinooge

发表

Accessing Targeted Therapies: A Potential Roadblock to Implementing Precision Oncology?

Jason Y. Park, A. Freedman, D. Gerber, 2021, JCO Oncology Practice.

Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance.

A. Jemal, D. Bajorin, S. Giordano, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Friends of Cancer Research Real‐World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies

R. Pe Benito, L. Enewold, L. Kushi, 2021, Clinical pharmacology and therapeutics.

Association Between Geographic Access to Cancer Care and Receipt of Radiation Therapy for Rectal Cancer.

A. Jemal, D. Bajorin, S. Giordano, 2016, International journal of radiation oncology, biology, physics.

Where do patients with cancer in Iowa receive radiation therapy?

G. Rushton, M. Ward, D. Bajorin, 2014, Journal of oncology practice.

Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists

G. Silvestri, R. Osarogiagbon, Caroline Schenkel, 2021, Cancer medicine.

Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement.

Nadine J Barrett, W. McCaskill-Stevens, E. Yang, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Insurance denials for cancer clinical trial participation after the Affordable Care Act mandate

Jarron M. Saint Onge, Shellie D. Ellis, J. S. Saint Onge, 2017, Cancer.

Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO–Friends of Cancer Research Joint Research Statement

Edward S. Kim, R. Schilsky, Caroline Schenkel, 2021, Clinical Cancer Research.

Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non–Small Cell Lung Cancer: Real-World Analysis of Select ASCO-Friends Recommendations

Edward S. Kim, R. Schilsky, W. Rubinstein, 2021, Clinical Cancer Research.

Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.

Laura A. Levit, Edward S. Kim, R. Schilsky, 2020, JCO oncology practice.

The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey.

Laura A. Levit, R. Schilsky, Laura A Levit, 2018, Journal of oncology practice.

Oncologists' Perspectives on Individualizing Dose Selection for Patients With Metastatic Cancer

Laura A. Levit, Laura A Levit, Caroline Schenkel, 2022, JCO oncology practice.

Impact of broadening clinical trial eligibility criteria for advanced non-small cell lung cancer patients: Real-world analysis.

Edward S. Kim, R. Schilsky, W. Rubinstein, 2019, Journal of Clinical Oncology.

The changing face of research in community practice.

R. Zon, A. Lyss, S. Bruinooge, 2014, Journal of oncology practice.

Challenges and opportunities to developing a frailty index using electronic health record data.

Laura A. Levit, Laura A Levit, Robert S. Miller, 2021, Journal of geriatric oncology.

Addressing Administrative and Regulatory Burden in Cancer Clinical Trials: Summary of a Stakeholder Survey and Workshop Hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes.

Laura A. Levit, J. Vose, Laura A Levit, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Palbociclib in Patients With Pancreatic and Biliary Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Edward S. Kim, Susan Halabi, Elizabeth Garrett-Mayer, 2019, JCO precision oncology.

Palbociclib in Patients With Non-Small-Cell Lung Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

R. Schilsky, C. Calfa, E. Garrett-Mayer, 2020, JCO precision oncology.

Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

R. Schilsky, E. Garrett-Mayer, S. Halabi, 2020, Targeted Oncology.

Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working Group.

Caroline Schenkel, Martha Donoghue, F. Balis, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement.

Laura A. Levit, H. Cohen, Laura A Levit, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.

Maximilian Diehn, Brooke L. Billman, Richard L Schilsky, 2018, Archives of pathology & laboratory medicine.

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group.

Caroline Schenkel, M. Rudek, K. Dunleavy, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.

Brooke L. Billman, C. Compton, R. Schilsky, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.

Edward S. Kim, Richard L Schilsky, Elizabeth Garrett-Mayer, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Challenges to National Cancer Institute-Supported Cooperative Group Clinical Trial Participation: An ASCO Survey of Cooperative Group Sites.

C. Runowicz, D. Blayney, S. Bruinooge, 2010, Journal of oncology practice.

Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies.

R. Schilsky, S. Bruinooge, S. Grubbs, 2019, Journal of oncology practice.

American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.

Laura A. Levit, M. Gönen, Laura A Levit, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Impact of Insurance on Access to Cancer Clinical Trials at a Comprehensive Cancer Center

C. Rudin, J. Ford, N. Kanarek, 2010, Clinical Cancer Research.

Rationale and Design of the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Edward S. Kim, R. Schilsky, E. Voest, 2018, JCO precision oncology.

Modernizing Eligibility Criteria for Molecularly Driven Trials.

Edward S. Kim, R. Schilsky, K. Hunt, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care.

Jonathan M Marron, Laura A. Levit, R. Schilsky, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working Group.

Caroline Schenkel, L. Fehrenbacher, N. Roach, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

R. Schilsky, A. Alva, C. Calfa, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group

K. Wilner, G. Lyman, Caroline Schenkel, 2021, Clinical Cancer Research.

Future supply and demand for oncologists : challenges to assuring access to oncology services.

Suanna S Bruinooge, Clese Erikson, Edward Salsberg, 2007, Journal of oncology practice.

Access to chemotherapy services by availability of local and visiting oncologists.

G. Rushton, M. Ward, D. Bajorin, 2014, Journal of oncology practice.

Understanding the Role of Advanced Practice Providers in Oncology in the United States

Caroline Schenkel, W. Vogel, M. Rosenzweig, 2018, Journal of the advanced practitioner in oncology.

Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage.

P. Hogan, D. Bajorin, Wenya Yang, 2014, Journal of oncology practice.

Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement.

Lori M. Minasian, Laura A. Levit, Wendy Demark-Wahnefried, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of Transgender People With Cancer in Electronic Health Records: Recommendations Based on CancerLinQ Observations.

E. Stepanski, Robert S. Miller, D. Dizon, 2021, JCO oncology practice.

Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO Registry

R. Schilsky, J. Gralow, A. Jazieh, 2021, JCO oncology practice.

Reviewing cancer care team effectiveness.

Sallie J. Weaver, S. Taplin, S. Weaver, 2015, Journal of oncology practice.

Enhancing the American Society of Clinical Oncology workforce information system with geographic distribution of oncologists and comparison of data sources for the number of practicing oncologists.

D. Bajorin, Suanna S Bruinooge, M. Kosty, 2014, Journal of oncology practice.

Teams and teamwork during a cancer diagnosis: interdependency within and between teams.

Sallie J. Weaver, S. Taplin, L. Marks, 2015, Journal of oncology practice.

Tracking the workforce: the American Society of Clinical Oncology workforce information system.

D. Bajorin, Suanna S Bruinooge, M. Kosty, 2013, Journal of oncology practice.

An Assessment of the Feasibility and Utility of an ACCC-ASCO Implicit Bias Training Program to Enhance Racial and Ethnic Diversity in Cancer Clinical Trials

E. Yang, K. Matin, A. Howson, 2023, JCO oncology practice.

Increasing Racial and Ethnic Equity, Diversity, and Inclusion in Cancer Treatment Trials: Evaluation of an ASCO-Association of Community Cancer Centers Site Self-Assessment

W. McCaskill-Stevens, L. Fashoyin-Aje, A. Ramirez, 2023, JCO oncology practice.

Availability of data for screening, offering, and consenting patients to cancer clinical trials: Report from an ASCO-ACCC collaboration.

W. McCaskill-Stevens, L. Fashoyin-Aje, A. Ramirez, 2022, Journal of Clinical Oncology.

Recommendations to Streamline and Standardize Clinical Trial Site Feasibility Assessments: An ASCO Research Statement.

Edward S. Kim, R. Schilsky, D. Waterhouse, 2021, JCO oncology practice.

The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.

W. McCaskill-Stevens, K. Weinfurt, M. Fouad, 2013, Journal of oncology practice.

Understanding the role of advanced practice providers in oncology in the United States

Caroline Schenkel, W. Vogel, M. Rosenzweig, 2018, JAAPA : official journal of the American Academy of Physician Assistants.

Rate of COVID‐19 vaccination among patients with cancer who tested positive for severe acute respiratory syndrome‐coronavirus 2: Analysis of the American Society of Clinical Oncology Registry

J. Gralow, E. Garrett-Mayer, X. Lei, 2023, Cancer.

Reaffirming and Clarifying the American Society of Clinical Oncology’s Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment

Laura A. Levit, M. Gönen, A. Dicker, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

National Cancer Institute-American Society of Clinical Oncology Teams in Cancer Care Project.

S. Taplin, M. Kosty, Amy E Hanley, 2016, Journal of oncology practice.

The impact of the privacy rule on cancer research: variations in attitudes and application of regulatory standards.

R. Schilsky, J. Tepper, T. Lawrence, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intentional approach to team-based oncology care: evidence-based teamwork to improve collaboration and patient engagement.

J. Cox, M. Kosty, S. Bruinooge, 2015, Journal of oncology practice.

The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.

W. McCaskill-Stevens, K. Weinfurt, M. Fouad, 2013, Journal of oncology practice.

Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.

Edward S. Kim, R. Schilsky, N. Lin, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement.

Caroline Schenkel, L. Amiri-Kordestani, K. Phillips, 2023, The Lancet. Oncology.

Pembrolizumab (P) in patients (pts) with metastatic breast cancer (MBC) with high tumor mutational burden (HTMB): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

R. Schilsky, A. Alva, C. Calfa, 2019, Journal of Clinical Oncology.

Researcher Experience and Comfort With Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials

Laura A. Levit, Caroline Schenkel, A. Magnuson, 2023, The oncologist.

The Impact of Insurance on Access to Cancer Clinical Trials at a Comprehensive Cancer Center

C. Rudin, J. Ford, N. Kanarek, 2010, Clinical Cancer Research.

Palbociclib (P) in patients (pts) with non-small cell lung cancer (NSCLC) with CDKN2A alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

R. Schilsky, C. Calfa, E. Garrett-Mayer, 2019, Journal of Clinical Oncology.